Eli Lilly (LLY) Change in Intangibles (2010 - 2024)
Eli Lilly (LLY) posted Change in Intangibles of $70.1 million for Q4 2024, up 23466.67% quarter-over-quarter from -$300000.0 in Q4 2023, and up 23466.67% year-on-year from N/an in Q1 2024.
Eli Lilly (LLY) Change in Intangibles (2010 - 2024) Analysis & Trends
Eli Lilly (LLY) has reported Change in Intangibles for 8 consecutive years, with $70.1 million the latest figure, recorded in Q4 2024.
- Change in Intangibles for Q4 2024 came in at $70.1 million, up 23466.67% year-over-year; the trailing twelve-month figure through Dec 2024 was $599.8 million (up 13.21% YoY), and the FY2025 annual result was $218.0 million, down 63.73% from the prior year.
- Change in Intangibles was $70.1 million for Q4 2024 at Eli Lilly, up from -$300000.0 in the prior quarter.
- Over five years, Change in Intangibles peaked at $500.0 million in Q2 2023 and troughed at -$300000.0 in Q4 2023.
- Average Change in Intangibles over 3 years is $150.0 million, with a median of $50.0 million recorded in 2022.
- Year-over-year, Change in Intangibles slumped 101.0% in 2023 and surged 23466.67% in 2024.
- Over 3 years, Change in Intangibles stood at $30.0 million in 2022, then sank by 101.0% to -$300000.0 in 2023, then soared by 23466.67% to $70.1 million in 2024.
- Per Business Quant data, the three most recent Change in Intangibles figures were $70.1 million in Q4 2024, -$300000.0 in Q4 2023, and $500.0 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -991.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -461.00 Mn |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 70.10 Mn |
| Dec 31, 2024 | 70.10 Mn |
| Dec 31, 2023 | -300,000.00 |
| Dec 31, 2023 | -300,000.00 |
| Jun 30, 2023 | 500.00 Mn |
| Jun 30, 2023 | 500.00 Mn |
| Dec 31, 2022 | 30.00 Mn |
| Dec 31, 2022 | 30.00 Mn |
| Dec 31, 2014 | 100,000.00 |
| Dec 31, 2014 | 100,000.00 |
| Sep 30, 2014 | 236.90 Mn |
| Sep 30, 2014 | 236.90 Mn |
| Jun 30, 2014 | 46.30 Mn |
| Jun 30, 2014 | 46.30 Mn |
| Mar 31, 2014 | 25.00 Mn |
| Mar 31, 2014 | 25.00 Mn |
| Dec 31, 2013 | 24.10 Mn |
| Dec 31, 2013 | 24.10 Mn |
| Jun 30, 2012 | 34.30 Mn |
| Jun 30, 2012 | 34.30 Mn |